Latest stories on CNSP
This AI Infrastructure Stock Could Benefit From a Connection Crisis
The Motley Fool63 · neutralproduct/pr
CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment
TipRanks56 · neutralgeneral
CNS Pharmaceuticals, Inc. (CNSP) files 8-K
SEC 8-K50 · neutralgeneral
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
Yahoo Finance64 · neutralanalyst
CNS Pharmaceuticals reports Q1 results
Seeking Alpha50 · neutralearnings